Some types of non-Hodgkin lymphoma grow and spread slowly and are called indolent. Others grow and spread quickly and are called aggressive. Treatment depends on the type and how far it has spread in your body.Chemotherapy is medicine used to treat cancer by killing tumor cells. Chemotherapy ...
What is malignant melanoma? What is inoperable esophageal cancer? What is multifocal superficial basal cell carcinoma? What is metastatic sarcoma cancer? What is thymic carcinoma cancer? What is indolent non-Hodgkin lymphoma? What is metastatic carcinoma cancer? What kind of cancer is non-Hodgkin ly...
How fast does B-cell lymphoma spread?Some types are aggressive (fast-spreading) and some types are indolent (slow-spreading). How aggressive is large B-cell lymphoma?Large B-cell lymphoma is a fast-growing type of cancer. Does B-cell lymphoma run in families?Diffuse large B-cell lymphoma ...
Introduction: The treatment of hematological malignancies in older adults is an emerging and important issue due to the aging population trend as well as drug-related toxicities in pts (pts) with comorbidities. Indolent lymphomas constitute a subgroup of incurable non-Hodgkin lymphomas characterized by...
Your doctor will only recommend watchful waiting if your disease is "indolent," which means that it's slow growing and not getting worse. To see if you're in that situation, they'll check your symptoms closely and look at the cancer cells under a microscope. ...
Indolent non-Hodgkin lymphoma is a category for several types of non-Hodgkin lymphoma that share the common characteristics of being slow-growing and...Become a member and unlock all Study Answers Start today. Try it now Create an account Ask a question Our experts can answer your tough ...
Robert Coleman, MD, FACOG, FACS:Mike, is this a typical presentation for a patient who has uterine-confined endometrial cancer? Michael J. Birrer, MD, PhD:This a typical presentation with a couple of caveats. First, from a clinical biologic standpoint, she has a fairly high BMI [body m...
Until recently, most immunotherapeutic approaches used to fight cancer were ineffective, counteracted by the tumour’s ability to evade immune attack. However, extensive research has improved our understanding of tumour immunology and enabled the develop
chemotherapy-naïve mCRPC is prospectively evaluating this patient population. Encouraging results have also been observed in ipilimumab clinical trials in patients with advanced lung cancer. In a phase 2 trial, there was a trend towards improved survival in patients who received ipilimumab 10 mg/kg...
What is indolent non-Hodgkin lymphoma? What is medullary carcinoma cancer? What is a lung cancer screening? What is a non-myeloid malignancy? What's the difference between COPD and lung cancer? What is stage 4 adenocarcinoma lung cancer? What is a lung cancer doctor called? What is non-Hod...